Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Denali Therapeutics
Research
Denali Alzheimer's antibody clears plaques without ARIA in mice
The Bay Area biotech plans to bring an optimized form of the antibody, which targets beta amyloid, into the clinic in 2026.
Darren Incorvaia
Aug 7, 2025 2:00pm
Blocking enzyme saved mice from known Parkinson’s mechanism
Jul 2, 2025 5:26pm
Denali’s ALS drug comes up short in trial extension
Mar 6, 2025 8:20am
Denali rare disease drug clears safety study, reduces biomarkers
Feb 6, 2025 12:05pm
Tenvie takes off with $200M, assets and exec from Denali
Jan 8, 2025 8:00am
Rival AbbVie and Denali prospects flunk phase 2/3 ALS tests
Jan 7, 2025 5:52am
